Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute ...

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...

Verona's approval of ensifentrine in COPD offers promising potential with its MoA and safety profile in a competitive market.

A “game changing" new discovery could completely revolutionise treatment for both asthma sufferers and COPD patients ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

A new study suggests that nicotinamide riboside (a form of vitamin B3) may reduce lung inflammation in COPD patients, with ...

Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...

King's College London trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30% ...

Merck said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients with a rare condition ...